Impact of NAD(P)H oxidase p22phox gene polymorphism on vascular aging in Korean centenarian and nonagenarian

International Journal of Cardiology

Volumn 123, Issue 1, 2007, Pages 18-22

  Kim, Kwang Il ^a,b   Na, Jung Eun ^b   Kang, Seo Young ^b   Cho, Young Seok ^a,b   Choi, Dong Ju ^a,b   Kim, Cheol Ho ^a,b   Kim, Hyo Soo ^a,c   Oh, Byung Hee ^a,c   Choi, Yoon Ho ^d   Kwon, In Soon ^e   Park, Sang Chul ^a  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e Inje University College of Medicine   (South Korea)

Author keywords

Centenarian study; p22phox polymorphism; Vascular aging

Indexed keywords

PROTEIN P22; PROTEIN P22PHOX; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; UNCLASSIFIED DRUG;

AGED; AGING; ARTICLE; CARDIOVASCULAR SYSTEM; DNA POLYMORPHISM; ENZYME ACTIVITY; EXON; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HYPERTENSION; KOREA; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STATISTICAL SIGNIFICANCE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC HYPERTENSION;

ADULT; AGED; AGED, 80 AND OVER; AGING; BLOOD VESSELS; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; KOREA; MALE; MIDDLE AGED; NADPH OXIDASE; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC;

EID: 36148947126     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2006.11.105     Document Type: Article

References (17)

1. Droge W. Free radicals in the physiological control of cell function. Physiol Rev 82 (2002) 47-95
2. Babior B.M. NADPH oxidase: an update. Blood 93 (1999) 1464-1476
3. Soccio M., Toniato E., Evangelista V., Carluccio M., and De Caterina R. Oxidative stress and cardiovascular risk: the role of vascular NAD(P)H oxidase and its genetic variants. Eur J Clin Invest 35 (2005) 305-314
4. Cahilly C., Ballantyne C.M., Lim D.S., Gotto A., and Marian A.J. A variant of p22(phox), involved in generation of reactive oxygen species in the vessel wall, is associated with progression of coronary atherosclerosis. Circ Res 86 (2000) 391-395
5. Dinauer M.C., Pierce E.A., Bruns G.A., Curnutte J.T., and Orkin S.H. Human neutrophil cytochrome b light chain (p22-phox). Gene structure, chromosomal location, and mutations in cytochrome-negative autosomal recessive chronic granulomatous disease. J Clin Invest 86 (1990) 1729-1737
6. Parkos C.A., Dinauer M.C., Walker L.E., Allen R.A., Jesaitis A.J., and Orkin S.H. Primary structure and unique expression of the 22-kilodalton light chain of human neutrophil cytochrome b. Proc Natl Acad Sci U S A 85 (1988) 3319-3323
7. Schachinger V., Britten M.B., Dimmeler S., and Zeiher A.M. NADH/NADPH oxidase p22 phox gene polymorphism is associated with improved coronary endothelial vasodilator function. Eur Heart J 22 (2001) 96-101
8. Ito D., Murata M., Watanabe K., et al. C242T polymorphism of NADPH oxidase p22 PHOX gene and ischemic cerebrovascular disease in the Japanese population. Stroke 31 (2000) 936-939
9. Choi Y.H., Kim J.H., Kim D.K., et al. Distributions of ACE and APOE polymorphisms and their relations with dementia status in Korean centenarians. J Gerontol A Biol Sci Med Sci 58 (2003) 227-231
10. Inoue N., Kawashima S., Kanazawa K., Yamada S., Akita H., and Yokoyama M. Polymorphism of the NADH/NADPH oxidase p22 phox gene in patients with coronary artery disease. Circulation 97 (1998) 135-137
11. Shimo-Nakanishi Y., Hasebe T., Suzuki A., et al. Functional effects of NAD(P)H oxidase p22(phox) C242T mutation in human leukocytes and association with thrombotic cerebral infarction. Atherosclerosis 175 (2004) 109-115
12. Evert J., Lawler E., Bogan H., and Perls T. Morbidity profiles of centenarians: survivors, delayers, and escapers. J Gerontol A Biol Sci Med Sci 58 (2003) 232-237
13. Lakatta E.G., and Levy D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation 107 (2003) 139-146
14. Zalba G., San Jose G., Moreno M.U., et al. Oxidative stress in arterial hypertension: role of NAD(P)H oxidase. Hypertension 38 (2001) 1395-1399
15. Hayaishi-Okano R., Yamasaki Y., Kajimoto Y., et al. Association of NAD(P)H oxidase p22 phox gene variation with advanced carotid atherosclerosis in Japanese type 2 diabetes. Diabetes Care 26 (2003) 458-463
16. Renner W., Schallmoser K., Gallippi P., et al. C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease. Atherosclerosis 152 (2000) 175-179
17. Li A., Prasad A., Mincemoyer R., et al. Relationship of the C242T p22phox gene polymorphism to angiographic coronary artery disease and endothelial function. Am J Med Genet 86 (1999) 57-61